Global Predictive Presymptomatic Testing Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Molecular Testing
  • 1.4.3 Cytogenic Testing
  • 1.4.4 Biochemical Testing
• 1.5 Market by Application
  • 1.5.1 Global Predictive Presymptomatic Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Breast and Ovarian Cancer
  • 1.5.3 Colorectal Cancer
  • 1.5.4 Alzheimer's Disease
  • 1.5.5 Multiple Endocrine Neoplasia Type 2
  • 1.5.6 Haemochromatosis
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Predictive Presymptomatic Testing Market Perspective (2015-2026)
• 2.2 Predictive Presymptomatic Testing Growth Trends by Regions
  • 2.2.1 Predictive Presymptomatic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Predictive Presymptomatic Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Predictive Presymptomatic Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Predictive Presymptomatic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Predictive Presymptomatic Testing Players by Market Size
  • 3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Predictive Presymptomatic Testing Market Concentration Ratio
  • 3.2.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2019
• 3.3 Predictive Presymptomatic Testing Key Players Head office and Area Served
• 3.4 Key Players Predictive Presymptomatic Testing Product Solution and Service
• 3.5 Date of Enter into Predictive Presymptomatic Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2021-2026)

5 Predictive Presymptomatic Testing Breakdown Data by Application (2015-2026)

• 5.1 Global Predictive Presymptomatic Testing Market Size by Application (2015-2020)
• 5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Predictive Presymptomatic Testing Market Size (2015-2020)
• 6.2 Predictive Presymptomatic Testing Key Players in North America (2019-2020)
• 6.3 North America Predictive Presymptomatic Testing Market Size by Type (2015-2020)
• 6.4 North America Predictive Presymptomatic Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Predictive Presymptomatic Testing Market Size (2015-2020)
• 7.2 Predictive Presymptomatic Testing Key Players in Europe (2019-2020)
• 7.3 Europe Predictive Presymptomatic Testing Market Size by Type (2015-2020)
• 7.4 Europe Predictive Presymptomatic Testing Market Size by Application (2015-2020)

(2015-2020)

(2015-2020)

(2015-2020)

(2015-2020)

8 Key Players Profiles

• 8.1 23andMe, Inc.
  • 8.1.1 23andMe, Inc. Company Details
  • 8.1.2 23andMe, Inc. Business Overview and Its Total Revenue
  • 8.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
  • 8.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2015-2020))
  • 8.1.5 23andMe, Inc. Recent Development
• 8.2 Abbott Laboratories
  • 8.2.1 Abbott Laboratories Company Details
  • 8.2.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 8.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
  • 8.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.2.5 Abbott Laboratories Recent Development
• 8.3 Bayer HealthCare AG
  • 8.3.1 Bayer HealthCare AG Company Details
  • 8.3.2 Bayer HealthCare AG Business Overview and Its Total Revenue
  • 8.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
  • 8.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.3.5 Bayer HealthCare AG Recent Development
• 8.4 Biocartis SA
  • 8.4.1 Biocartis SA Company Details
  • 8.4.2 Biocartis SA Business Overview and Its Total Revenue
  • 8.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
  • 8.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.4.5 Biocartis SA Recent Development
• 8.5 BioHelix Corporation
  • 8.5.1 BioHelix Corporation Company Details
  • 8.5.2 BioHelix Corporation Business Overview and Its Total Revenue
  • 8.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
  • 8.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.5.5 BioHelix Corporation Recent Development
• 8.6 bioMerieux S.A.
  • 8.6.1 bioMerieux S.A. Company Details
  • 8.6.2 bioMerieux S.A. Business Overview and Its Total Revenue
  • 8.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
  • 8.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.6.5 bioMerieux S.A. Recent Development
• 8.7 Celera Corporation (Quest Diagnostics)
  • 8.7.1 Celera Corporation (Quest Diagnostics) Company Details
  • 8.7.2 Celera Corporation (Quest Diagnostics) Business Overview and Its Total Revenue
  • 8.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
  • 8.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.7.5 Celera Corporation (Quest Diagnostics) Recent Development
• 8.8 Cepheid (Danaher)
  • 8.8.1 Cepheid (Danaher) Company Details
  • 8.8.2 Cepheid (Danaher) Business Overview and Its Total Revenue
  • 8.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
  • 8.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.8.5 Cepheid (Danaher) Recent Development
• 8.9 Daan Diagnostics Ltd.
  • 8.9.1 Daan Diagnostics Ltd. Company Details
  • 8.9.2 Daan Diagnostics Ltd. Business Overview and Its Total Revenue
  • 8.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
  • 8.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.9.5 Daan Diagnostics Ltd. Recent Development
• 8.10 EKF Diagnostics Holdings plc
  • 8.10.1 EKF Diagnostics Holdings plc Company Details
  • 8.10.2 EKF Diagnostics Holdings plc Business Overview and Its Total Revenue
  • 8.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
  • 8.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2015-2020)
  • 8.10.5 EKF Diagnostics Holdings plc Recent Development

9 Analyst's Viewpoints/Conclusions

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Disclaimer